Advertisement

Topics

Extension study data supporting long-term safety and efficacy of Eloctate®/Elocta® published in Haemophilia

09:02 EDT 10 Aug 2015 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
- Interim results show participants maintained low bleeding rates with prophylactic dosing Newly published clinical data demonstrate that people on extended-interval prophylaxis regimens with Eloctate®/Elocta® (rFVIIIFc) [Antihemophilic Factor (Re...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Extension study data supporting long-term safety and efficacy of Eloctate®/Elocta® published in Haemophilia "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...